Brazil Atopic Dermatitis Drugs Market: Segmented by Drug Class (Corticosteroids, PDE4 Inhibitors, Biologics, Skin Barrier Emollients, CNI Immunosuppressants and Others) and Route of Administration (Oral, Topical and Injectable) - Growth, Trends, and Forecasts (2019 2028)
- Published Date: 2022-12-28
- Report ID: 140060
- Pages: 200
-
Format:
Report Overview
The Brazil Atopic Dermatitis Drugs market size stood at around USD 280 million in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Atopic Dermatitis is an inflammatory skin disease. The degree of its severity varies from patient to patient. It usually begins in childhood and is mostly confined to the flexural surfaces of the body. It is highly prevalent. It is more commonly known as eczema. Itching, redness of the skin, cracking, weeping, etc. are symptoms of it. It is a long-term disease. Low humidity, cold weather, seasonal allergies are the common causes of it. The pattern of the disease and its severity determine the kind of treatment it ought to receive.
Market Drivers
The Brazilian atopic dermatitis drugs market is driven by the rising patient population all over the country. The market is expected to grow with the newer treatment methods, biologics and improvement in the diagnostics technology. Additionally, climate change and large pipeline products provides scope for the growth of market.
1. Brazil Atopic Dermatitis Drugs Market Overview.......................................
A. Market Size
2. Market Growth Drivers...
A. Rising patient population
B. Newer treatment methods, biologics and improvement in technology
3. Major Atopic Dermatitis Types..
A. Atopic dermatitis
B. Contact dermatitis
C. Neurodermatitis
D. Dyshidrotic eczema
E. Nummular eczema
F. Seborrheic dermatitis
G. Stasis dermatitis
4. Brazil Atopic Dermatitis Drugs Market Segmentation...........................
A. By Drug Class
I. Corticosteroids
II. PDE4 Inhibitors, Biologics
III. Skin Barrier Emollients
IV. CNI Immunosuppressants
V. Others
B. By Route of Administration
I. Oral
II. Topical
III. Injectable
5. Atopic Dermatitis Drugs Major Products Market Share
A. Key Findings
B. Market Analysis, Insights and Forecast By Drug Type
6. Competitive Landscape...
A. Major Players
B. Products in Pipeline
7. Key Company Profiles..
A. Astellas Pharma Inc. Company overview, Product & Services, Strategies & Financials
B. Valeant Pharmaceuticals International, Inc. Company overview, Product & Services, Strategies & Financials
C. Sanofi S.A. Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape.
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth
A. New Trends and Development of Atopic Dermatitis Drugs market
B. Future Opportunities
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
